CLINICAL_TRIALS
trial_result
· 2021-08-02
Clinical Trial Update: Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery [Phase 2]
Summary
Phase 2 trial assessing safety and efficacy of EXC 001 to improve appearance of scars from prior breast surgery has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Scar Prevention | Phase 2 | Status: COMPLETED | Results posted: 2021-08-02